Literature DB >> 26071550

Cardiovascular and thermoregulatory dysregulation over 24 h following acute heat stress in rats.

Carrie M Quinn1, Gerald N Audet2, Nisha Charkoudian2, Lisa R Leon2.   

Abstract

The influences of severe heat stroke (HS) on cardiovascular function during recovery are incompletely understood. We hypothesized that HS would elicit a heart rate (HR) increase persisting through 24 h of recovery due to hemodynamic, thermoregulatory, and inflammatory events, necessitating tachycardia to support mean arterial pressure (MAP). Core temperature (Tc), HR, and MAP were measured via radiotelemetry in conscious male Fischer 344 rats (n = 22; 282.4 ± 3.5 g) during exposure to 37°C ambient temperature until a maximum Tc of 42.0°C, and during recovery at 20°C ambient temperature through 24 h. Rats were divided into Mild, Moderate, and Severe groups based on pathophysiology. HS rats exhibited hysteresis relative to Tc with HR higher for a given Tc during recovery compared with heating (P < 0.0001). "Reverse" hysteresis occurred in MAP with pressure during cooling lower than heating per degree Tc (P < 0.0001). Mild HS rats showed tachycardia [P < 0.01 vs. control (Con)] through 8 h of recovery, elevated MAP (P < 0.05 vs. Con) for the initial 5 h of recovery, with sustained hyperthermia (P < 0.05 vs. Con) through 24 h. Moderate HS rats showed significant tachycardia (P < 0.01 vs. Con), normal MAP (P > 0.05 vs. Con), and rebound hyperthermia from 4 to 24 h post-HS (P < 0.05 vs. Con). Severe HS rats showed tachycardia (P < 0.05 vs. Con), hypotension (P < 0.01 vs. Con), and hypothermia for 24 h (P < 0.05 vs. Con). Severe HS rats showed 14- and 12-fold increase in heart and liver inducible nitric oxide synthase expression, respectively. Hypotension and hypothermia in Severe HS rats was consistent with inducible nitric oxide synthase-mediated systemic vasodilation. These findings provide mechanistic insight into hemodynamic and thermoregulatory impairments during 24 h of HS recovery.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  autonomic nervous system; blood pressure; heart rate; heat stroke; iNOS; thermoregulation

Mesh:

Year:  2015        PMID: 26071550     DOI: 10.1152/ajpheart.00918.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Transcriptome Sequencing Reveals Astrocytes as a Therapeutic Target in Heat-Stroke.

Authors:  Bing Niu; Tao Zhang; Huaiqiang Hu; Bingzhen Cao
Journal:  Neurosci Bull       Date:  2017-07-11       Impact factor: 5.203

Review 2.  Pathophysiology of heatstroke in dogs - revisited.

Authors:  Yaron Bruchim; Michal Horowitz; Itamar Aroch
Journal:  Temperature (Austin)       Date:  2017-10-09

3.  Pretreatment with indomethacin results in increased heat stroke severity during recovery in a rodent model of heat stroke.

Authors:  Gerald N Audet; Shauna M Dineen; Delisha A Stewart; Mark L Plamper; Wimal W Pathmasiri; Susan L McRitchie; Susan J Sumner; Lisa R Leon
Journal:  J Appl Physiol (1985)       Date:  2017-06-08

Review 4.  Hypotensive effects of melatonin in rats: Focus on the model, measurement, application, and main mechanisms.

Authors:  Diana Cvikova; Hana Sutovska; Katarina Babarikova; Lubos Molcan
Journal:  Hypertens Res       Date:  2022-09-20       Impact factor: 5.528

Review 5.  Human temperature regulation under heat stress in health, disease, and injury.

Authors:  Matthew N Cramer; Daniel Gagnon; Orlando Laitano; Craig G Crandall
Journal:  Physiol Rev       Date:  2022-06-09       Impact factor: 46.500

6.  Biphasic changes in spontaneous cardiovagal baroreflex sensitivity during passive hyperthermia.

Authors:  Marian Turcani; Elham Ghadhanfar
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

7.  Salidroside pretreatment protects against myocardial injury induced by heat stroke in mice.

Authors:  Guo-Dong Chen; Heng Fan; Jian-Hua Zhu
Journal:  J Int Med Res       Date:  2019-08-26       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.